Lariago 50mg Suspension

Product Introduction

Lariago 50mg Suspension is a pharmaceutical preparation primarily used for the treatment of malaria. It contains the active ingredient Lariam (mefloquine), a potent antimalarial agent. Lariago is formulated as an oral suspension, making it easier to administer, especially to children and individuals who may have difficulty swallowing tablets. The suspension has a measured concentration of 50 mg of mefloquine per 5 ml, ensuring accurate dosing.

The medicine is manufactured in compliance with rigorous quality standards and is intended to provide an effective means of preventing and treating malaria, a serious and sometimes life-threatening illness caused by parasites transmitted through mosquito bites.

Uses of Lariago 50mg Suspension

Lariago 50mg Suspension is primarily indicated for the following uses:

• Treatment of Acute Malaria: It is effective in treating uncomplicated malaria caused by Plasmodium falciparum and Plasmodium vivax. It works by interfering with the parasite’s ability to metabolize and replicate, thereby alleviating the symptoms of malaria.
• Prophylaxis (Prevention) of Malaria: Lariago is also used for the prevention of malaria in travelers to areas where the disease is prevalent. By taking the medication before and during travel, individuals can reduce their risk of contracting malaria.
• Treatment of Relapses: In cases of malaria relapse, especially with Plasmodium vivax, Lariago is used in conjunction with other antimalarial drugs to clear the infection completely.

Benefits of Lariago 50mg Suspension

Lariago 50mg Suspension offers several benefits:

• Effective Antimalarial Activity: Mefloquine, the active ingredient, has a broad-spectrum efficacy against malaria parasites, including strains resistant to other antimalarial drugs. This makes it a reliable option in regions with resistant strains.
• Convenient Formulation: The suspension form of Lariago makes it suitable for children and adults who may have difficulty swallowing tablets. This enhances patient compliance and ensures accurate dosing.
• Proven Track Record: Lariago has been used successfully for many years in malaria-endemic regions, demonstrating its effectiveness and safety profile in various populations.
• Prevention and Treatment: The dual use of Lariago for both treatment and prophylaxis provides a comprehensive approach to managing malaria, reducing the incidence and severity of the disease.

Side Effects of Lariago 50mg Suspension

Like all medications, Lariago 50mg Suspension can cause side effects, although not everyone will experience them. Common side effects include:

• Gastrointestinal Issues: Nausea, vomiting, diarrhea, and abdominal pain are frequent complaints. These side effects are generally mild and often resolve on their own.
• Central Nervous System Effects: Dizziness, headache, and sleep disturbances can occur. In some cases, more serious effects such as confusion, hallucinations, or seizures may be observed, particularly if the medication is taken in high doses or for prolonged periods.
• Allergic Reactions: Rarely, patients may experience allergic reactions, including rash, itching, or swelling. Severe reactions like anaphylaxis are extremely rare but require immediate medical attention.
• Psychiatric Effects: Mefloquine can cause mood changes or behavioral disturbances in some individuals. This can include anxiety, depression, or unusual thoughts or behaviors.
• Hepatic Effects: Liver function abnormalities have been reported, so liver function tests may be necessary in patients with pre-existing liver conditions.

FAQ

1. How should Lariago 50mg Suspension be administered?

Lariago should be taken orally. The dose is typically based on body weight and the specific condition being treated or prevented. It is important to follow the dosing instructions provided by your healthcare provider or as indicated on the prescription label. Shake the suspension well before use to ensure proper mixing.

2. Can Lariago 50mg Suspension be taken during pregnancy?

Lariago is generally not recommended during pregnancy, especially during the first trimester, unless the benefits outweigh the risks. It is crucial to consult a healthcare provider to assess the potential risks and benefits before using this medication during pregnancy.

3. What should I do if I miss a dose of Lariago 50mg Suspension?

If a dose is missed, take it as soon as you remember. However, if it is almost time for your next dose, skip the missed dose and continue with your regular dosing schedule. Do not double the dose to make up for a missed one.

4. Are there any interactions with other medications?

Yes, Lariago may interact with other medications, including certain antiepileptic drugs, antidepressants, and drugs affecting liver enzymes. Inform your healthcare provider about all other medications you are taking to avoid potential interactions.

5. How should Lariago 50mg Suspension be stored?

Store the suspension at room temperature, away from moisture and direct sunlight. Ensure the bottle is tightly closed when not in use. Keep it out of reach of children.

6. What should I do in case of an overdose?

In case of an overdose, seek immediate medical attention. Symptoms of an overdose may include severe dizziness, headache, nausea, vomiting, and potentially serious effects on the central nervous system.

Disclaimer

Singhla Medicos’s primary intention is to ensure that its consumers get information that is reviewed by experts, accurate and trustworthy. The information and contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on Singhla Medicos. Our mission is to support, not replace, the doctor-patient relationship.